跳轉至內容
Merck
  • Differential gene expression between human schwannoma and control Schwann cells.

Differential gene expression between human schwannoma and control Schwann cells.

Neuropathology and applied neurobiology (2006-11-07)
C O Hanemann, B Bartelt-Kirbach, R Diebold, K Kämpchen, S Langmesser, T Utermark
摘要

The NF2 gene encodes the tumour suppressor protein merlin. The mutation of a single allele of this gene causes the autosomal dominantly inherited disease neurofibromatosis type 2 (NF2), which is characterized mainly by vestibular schwannoma carrying a second hit mutation. Complete lack of merlin is also found in spontaneous schwannomas and meningiomas. As the events leading to schwannoma development are largely unknown we investigated the differences in gene expression between schwannoma cells from NF2 patients and normal human primary Schwann cells by cDNA array analysis. We identified 41 genes whose expression levels differed by more than factor 2. Most of these clones were corroborated by real-time reverse transcription polymerase chain reaction analysis. By this method a total of seven genes with increased and seven genes with decreased mRNA levels in schwannoma compared with normal Schwann cells could be identified. Regulated clones, some of which not been described in Schwann cells earlier, included matrix metalloproteinase's, growth factors, growth factor receptors and tyrosine kinases.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
Anti-Nerve Growth Factor Receptor (NGFR p75) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution